Global Next Generation Cancer Diagnostic Devices Market Forecast 2012-2016 by IndustryMonitor.co
Summary
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site Press Releases Industry Monitor Press Release Receive press releases from Industry Monitor: By Email RSS Feeds: Global Next Generation Cancer Diagnostic Devices Market Forecast 2012-2016 by IndustryMonitor.co New Market Research Report Added in IndustryMonitor.co Report Database Global Next Generation Cancer Diagnostic Devices Market 2012-20166 Albany, NY, March 11, 2013 --( To Buy The Copy Of This Report Visit: http://www.industrymonitor.co/report/164258-global TechNavios report, Global Next-generation Cancer Diagnostic Devices Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts.The key vendors dominating this space are Roche Holding Ltd., Abbott Laboratories, Siemens Healthcare, and Agilent Technologies Inc.To Buy The Copy Of This Report Visit: http://www.industrymonitor.co/report/164258-global For More Information Contact: Hemendra Parmar State Tower 90 State Street, Suite 700 Albany, NY 12207 United States Tel: +1-518-618-1030 sales@industrymonitor.co website: http://www.industrymonitor.co/ Blog: http://industrymonitorblog.blogspot.com/ Albany, NY, March 11, 2013 --( PR.com )-- TechNavios analysts forecast the Global Next-generation Cancer Diagnostic Devices market to grow at a CAGR of 48.11 percent over the period 2012-2016.The Global Next-generation Cancer Diagnostic Devices market has also been witnessing an increase in mergers and acquisitions among vendors.The report also includes a discussion of the key vendors operating in this market.The key vendors dominating this space are Roche Holding Ltd., Abbott Laboratories, Siemens Healthcare, and Agilent Technologies Inc.The other vendors mentioned in the report are Illumina Inc., Becton Dickinson and Co., QIAGEN N.V., Affymetrix Inc., Johnson & Johnson, Thermo Fisher Scientific Inc., GE Healthcare, Life Technologies Corp., Luminex Corp., Cepheid Inc., bioMerieux SA, Allegro Diagnostics Corp., Fluidigm Corp., Nanosphere Inc., PerkinElmer Inc., Randox Laboratories Ltd., Oncolys BioPharma Inc., SomaLogic Inc., Radient Pharmaceuticals Corp., Quest Diagnostics Inc., Asuragen Inc., AVIVA Biosciences Corp., Veridex LLC, A. Menarini Diagnostics S.r.l., and Fujirebio Diagnostics Inc.For Request The Sample Visit: http://www.industrymonitor.co/sample/sample/164258Key questions answered in this report:What will the market size be in 2016 and what will the growth rate be?What are the key market trends?What is driving this market?What are the challenges to market growth?Who are the key vendors in this market space?What are the market opportunities and threats faced by the key vendors?What are the strengths and weaknesses of each of these key vendors?To Buy The Copy Of This Report Visit: http://www.industrymonitor.co/report/164258-globalFor More Information Contact:Hemendra ParmarState Tower90 State Street, Suite 700Albany, NY 12207United StatesTel: +1-518-618-1030sales@industrymonitor.cowebsite: http://www.industrymonitor.co/Blog: http://industrymonitorblog.blogspot.com/ Contact Information IndustryMonitor Hemendra Pratap +1-518-618-1030 www.industrymonitor.co/ Click here to view the list of recent Press Releases from Industry Monitor Promote Your Business Press Release Pricing Email this page to a friend